Synbio Tech Inc. (1295:TT) recently announced that its probiotic product aimed at improving muscle mass and endurance in the elderly, Lactobacillus plantarum TWK10^®, has obtained a Japanese invention patent (Patent No.: JP7410569). This milestone not only symbolizes the commitment to scientific innovation but also strengthens Synbio Tech's leadership in the global health industry.
 
With the rapid growth of aging societies in Japan and globally, the health and quality of life of the elderly have become significant issues. Japan, being a highly aged country, urgently requires innovative products that can enhance the quality of life for the elderly. TWK10^® emerged in this context, improving muscle mass and endurance through the gut-muscle axis, thereby enhancing the mobility and dynamic balance of the elderly, further improving their quality of life.
 
The research and development of TWK10^® are based on a solid scientific foundation, with several clinical trials completed and published in international journals, proving its effectiveness in improving muscle health. The acquisition of the Japanese invention patent not only represents international recognition of TWK10^®'s scientific innovation but also symbolizes the potential of the product to improve the quality of life for the elderly and its prospects for expansion in the global aging market.
 
Synbio Tech is dedicated to promoting TWK10^®, a muscle probiotic derived from unique Taiwanese pickles, proven by scientific research to significantly improve muscle mass. By applying this unique probiotic to health products, the company aims to bring a healthier, more vibrant lifestyle to the elderly population worldwide.